Valuation: Precision Therapeutics Inc

Market Cap 83.34M 72.21M 67.65M 61.71M 116M 7.95B 118M 796M 311M 3.98B 313M 306M 13.27B P/E 2024
-0.35x
P/E 2025 -0.53x
Enterprise Value 74.22M 64.3M 60.25M 54.95M 103M 7.08B 105M 709M 277M 3.54B 279M 273M 11.82B EV / Sales 2024
4.23x
EV / Sales 2025 121x
Free-Float
94.34%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 57 09/02/2026
Director of Finance/CFO - 16/04/2026
President - 01/04/2026
Director TitleAgeSince
Director/Board Member 66 19/02/2020
Chairman 78 09/02/2026
Director/Board Member 60 09/07/2020
Change 5-day change 1-year change 3-year change Capi.($)
-7.56%-8.33% - - 83.34M
-1.60%+0.86%+3.70%+14.57% 49.54B
-0.05%+4.79%+486.36%+589.17% 44.06B
-0.30%+9.63%+24.64%+75.91% 40.85B
-0.27%+2.99%+30.77%+10.45% 40.14B
-4.04%+8.72%+22.60%+48.00% 34.17B
-0.49%+2.31%+30.93%+126.39% 16.9B
+0.92%+5.83% - - 16.78B
-0.43%-0.11%+4.22%+20.71% 14B
+1.54%+9.71%+87.25%+31.87% 13.46B
Average -1.15%+6.97%+86.31%+114.63% 29.99B
Weighted average by Cap. -0.71%+6.51%+104.22%+137.07%

Financials

2024 2025
Net sales 1.62M 1.41M 1.32M 1.2M 2.26M 155M 2.3M 15.5M 6.06M 77.55M 6.1M 5.96M 259M 125K 109K 102K 92.76K 174K 11.95M 177K 1.2M 468K 5.98M 470K 460K 19.95M
Net income -12.66M -10.97M -10.28M -9.38M -17.63M -1.21B -17.9M -121M -47.26M -605M -47.55M -46.52M -2.02B -233M -202M -189M -173M -324M -22.23B -329M -2.23B -870M -11.13B -875M -856M -37.12B
Net Debt 1.4M 1.21M 1.13M 1.03M 1.94M 133M 1.97M 13.33M 5.21M 66.68M 5.24M 5.13M 222M -9.12M -7.91M -7.41M -6.76M -12.7M -870M -12.9M -87.12M -34.05M -436M -34.26M -33.51M -1.45B
Logo Precision Therapeutics Inc
Axe Compute Inc. is a virtual neocloud AI infrastructure platform. The Company provides customers with access to graphics processing unit (GPU) compute capacity for artificial intelligence (AI) and other high-performance computing workloads through a distributed network model, including infrastructure made available through the Aethir network. It also operates a digital asset treasury focused on the Aethir token (ATH), the native utility token of the Aethir network. Its segments include Compute Services and Treasury Management and Drug Discovery Services. Its Drug Discovery Services segment provides services that include the application of AI using its proprietary biobank of tumor samples, as well as creation of proprietary 3D culture models used in drug development. The Company provides enterprises and AI innovators with flexibility across hardware, geography, and deployment models through two offerings: Axe Compute Access and Axe Compute Build.
Employees
-